In vitro evaluation of anticoagulant therapy management when urgent percutaneous coronary intervention is required in rivaroxaban-treated patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00210-023-02533-2.pdf
Reference29 articles.
1. Asmis LM, Alberio L, Angelillo-Scherrer A, Korte W, Mendez A, Reber G et al (2012) Rivaroxaban: quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories. Thromb Res 129:492–498. https://doi.org/10.1016/j.thromres.2011.06.031
2. Batra G, Svennblad B, Held C, Jernberg T, Johanson P, Wallentin L et al (2016) All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart 102:926–933. https://doi.org/10.1136/heartjnl-2015-308678
3. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844
4. Beyer J, Trujillo T, Fisher S, Ko A, Lind SE, Kiser TH (2016) Evaluation of a heparin-calibrated antifactor Xa assay for measuring the anticoagulant effect of oral direct Xa inhibitors. Clin Appl Thromb Hemost 22:423–428. https://doi.org/10.1177/1076029616629759
5. Braga CG, Ramos V, Martins J, Arantes C, Abreu G, Vieira C et al (2015) Impact of atrial fibrillation type during acute coronary syndromes: clinical features and prognosis. Rev Port Cardiol 34:403–410. https://doi.org/10.1016/j.repc.2015.01.010
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3